Mercado cerrado -
Otros sitios de cotización
|
Varia. Cinco días. | Varia. 1 de enero. | ||
0,293 USD | +12,65 % | -16,31 % | -78,30 % |
Resumen de negocios
Número de empleados: 80
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Manuel Litchman
CEO | Chief Executive Officer | 70 | 24/04/17 |
James Murphy
DFI | Director of Finance/CFO | 67 | 19/01 |
Michael Weiss
CHM | Chairman | 58 | 01/03/15 |
Greg Furrow
CTO | Chief Tech/Sci/R&D Officer | - | 01/01/19 |
Bruce Dezube
CTO | Chief Tech/Sci/R&D Officer | - | 01/06/21 |
Jaclyn Jaffe
IRC | Investor Relations Contact | - | - |
Peter Carney
AUD | Comptroller/Controller/Auditor | 38 | 01/08/21 |
Robert Sexton
PRN | Corporate Officer/Principal | - | 01/10/22 |
Rick Bodmer
PRN | Corporate Officer/Principal | - | 01/08/22 |
Lynn E. Bayless
LAW | General Counsel | - | 01/01/20 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Director/Board Member | 68 | 13/03/15 | |
Michael Weiss
CHM | Chairman | 58 | 01/03/15 |
Neil Herskowitz
BRD | Director/Board Member | 67 | 01/08/15 |
Adam Chill
BRD | Director/Board Member | 56 | 07/06/17 |
Manuel Litchman
CEO | Chief Executive Officer | 70 | 24/04/17 |
Michael Zelefsky
BRD | Director/Board Member | 63 | 07/06/17 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 845 385 | 0 | 0 | 70,95 % |
Acción B | 1 | 9 544 747 | 7 371 635 ( 77,23 %) | 0 | |
Acción C | 0 | 250 000 | 0 | 0 |
Información de la empresa
Mustang Bio, Inc.
377 Plantation Street 1st floor
01605-2245, Worcester
+781 652 4500
http://www.mustangbio.comSector
Varia. 1 de ene. | Capi. | |
---|---|---|
-78,30 % | 2,69 M | |
-1,65 % | 104 mil M | |
+6,75 % | 97,47 mil M | |
+5,71 % | 22,25 mil M | |
-12,60 % | 21,68 mil M | |
-9,70 % | 18,2 mil M | |
-39,98 % | 17,02 mil M | |
-10,17 % | 16,36 mil M | |
+6,12 % | 14,39 mil M | |
+35,47 % | 12,37 mil M |
- Bolsa de valores
- Acciones
- Acción MBIO
- Empresa Mustang Bio, Inc.